![]()
|
| |
John J. McIlvery | ||
Partner | ||
Direct Voice | 818.444.4502 | |
Direct Fax | 818.444.6302 | |
Mobile | 626.705.0758 jmcilvery@biztechlaw.com |
December 22, 2010
VIA EDGAR AND FACSIMILE
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | HemaCare Corporation | |
Form 10-K for the Fiscal Year Ended December 31, 2009 | ||
Filed on March 23, 2010 | ||
File No.: 000-15223 | ||
Schedule 14A | ||
Filed on March 31, 2010 | ||
File No.: 000-15223 |
Ladies and Gentlemen:
On behalf of our client, HemaCare Corporation (the “Company”), we respectfully request that the United States Securities and Exchange Commission Staff (the “Staff”) permit the Company additional time to reply to the Staff’s comment letter, dated December 13, 2010, addressed to Peter van der Wal, Chief Executive Officer. We request that the deadline for the Company’s response be extended to January 14, 2011.
If you have any questions or require any additional information or documents, please telephone me at (818) 444-4502.
Sincerely,
/s/ John J. McIlvery
John J. McIlvery
cc: Peter van der Wal
15260 Ventura Boulevard, 20th Floor, Sherman Oaks, California 91403
office>818.444.4500 fax>818.444.4520 www.biztechlaw.com